Drug profile · INN
levodopa + benserazide
MADOPAR RAPID 62.5
levodopa + benserazide (MADOPAR RAPID 62.5) is an FDA-listed pharmaceutical active ingredient. Associated with Hoffmann-La Roche.
TGA: approved
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — levodopa + benserazide
- Class
- —
- Route
- —
- Patents
- 0
- Programs
- 0
- Data quality
- 0.81
Quick answer
levodopa + benserazide (MADOPAR RAPID 62.5) is an FDA-listed pharmaceutical active ingredient. Associated with Hoffmann-La Roche.
Key facts
Approval history
| Authority | Status | Date |
|---|---|---|
| TGA | approved | — |
Frequently asked questions
What is levodopa + benserazide?
levodopa + benserazide (MADOPAR RAPID 62.5) is an FDA-listed pharmaceutical active ingredient. Associated with Hoffmann-La Roche.
What is the brand name for levodopa + benserazide?
MADOPAR RAPID 62.5 is a marketed brand name for levodopa + benserazide. Check FDA Drugs@FDA for the current US label holder and prescribing information.